Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial-Reference-Cited by-同舟云学术

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial

Published:2015-08 Issue:12 Volume:51 Page:1546-1554
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Sinn M.,Riess H.,Sinn B.V.,Stieler J.M.,Pelzer U.,Striefler J.K.,Oettle H.,Bahra M.,Denkert C.,Bläker H.,Lohneis P.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res,2014

2. European cancer mortality predictions for the year 2014;Malvezzi;Ann Oncol,2014

3. Pancreatic adenocarcinoma;Ryan;N Engl J Med,2014

4. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial;Oettle;JAMA,2013

5. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial;Neoptolemos;JAMA,2010

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Equilibrative Nucleoside Transporter 1: Novel Biomarker and Prognostic Indicator for Patients with Gemcitabine-Treated Pancreatic Cancer;Cancer Management and Research;2024-06

2. Barriers and opportunities for gemcitabine in pancreatic cancer therapy;American Journal of Physiology-Cell Physiology;2023-02-01

3. Role of drug catabolism, modulation of oncogenic signaling and tumor microenvironment in microbe-mediated pancreatic cancer chemoresistance;Drug Resistance Updates;2022-09

4. Class III β-Tubulin Expression Is of Value in Selecting nab-Paclitaxel and Gemcitabine as First-Line Therapy in Unresectable Pancreatic Cancer;Pancreas;2022-04

5. Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice;Hepatobiliary Surgery and Nutrition;2021-12